Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Should Patients With Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation Have Ventilatory Support Reduced to the Lowest Tolerable Settings? No

Shekar, Kiran MBBS, FCICM, FCCCM, PhD1,2; Brodie, Daniel MD3,4

doi: 10.1097/CCM.0000000000003865
Viewpoints
Buy

1Adult Intensive Care Services and Critical Care Research Group, the Prince Charles Hospital, Brisbane, QLD, Australia.

2University of Queensland and Bond University, QLD, Australia.

3Columbia University College of Physicians and Surgeons/New York-Presbyterian Hospital, New York, NY.

4Center for Acute Respiratory Failure, New York-Presbyterian Hospital, New York, NY.

Dr. Shekar has received grant funding from National Health and Medical Research Council, The Prince Charles Hospital Foundation, Intensive Care Foundation, Australia and New Zealand College of Anesthetists, Queensland Emergency Medicine Research Foundation, Defense Health Foundation, and the Extracorporeal Life Support Organization. His institution received funding from Abiomed. Dr. Brodie’s institution received funding from ALung Technologies (research support VENT-AVOID trial and medical advisory board); he received funding from Baxter (medical advisory board); and he disclosed that he will be on the BREETHE medical advisory board, and is on the Hemovent advisory board but it is unpaid.

For information regarding this article, E-mail: kiran.shekar@health.qld.gov.au

Copyright © 2019 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.